Uncoordinated price cuts across the EU are contributing to medicine shortages and driving manufacturers towards more ...

SHELTON, CONNECTICUT / ACCESS Newswire / July 16, 2025 / NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) ...

Korro Bio, Inc. (Korro) (Nasdaq: KRRO), a clinical-stage biopharmaceutical company focused on developing a new class of genetic medicines based on editing RNA for both rare and highly prevalent ...

Despite not meeting the endpoint, subjects have experienced a meaningful improvement in RBC transfusion independence.

Following the FDA ODD, European designation underscores ICT01’s potential as a ...

Novo Nordisk A/S (NYSE:NVO) is one of the 10 Best Growth Stocks to Buy With Huge Upside Potential. On June 23, Novo Nordisk A ...

Denmark's Novo Nordisk said on Tuesday it had submitted a new, higher dose of its obesity treatment Wegovy to the European Medicines Agency for approval, with one in three trial participants achieving ...

NanoViricides, Inc., a publicly traded company (NYSE Amer.: NNVC ) (the “Company”), and a clinical stage, leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic ...

REYKJAVIK, Iceland and LONDON, June 23, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for ...

The European Union’s health regulator has lifted the temporary restriction on the use of French drugmaker Valneva’s ...

The amended product information will provide more specific detail on encephalitis as a known adverse reaction to ...